Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bio-Gene Technology Ltd. (AU:BGT)
ASX:BGT
RESEARCH TOOLSreports
Holding AU:BGT?
Track your performance easily
BGT Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.04 - AU$0.09
Previous CloseAU$0.06
Volume0.00
Average Volume (3M)86.48K
Market Cap
AU$11.07M
Enterprise ValueAU$4.73M
Total Cash (Recent Filing)AU$6.34M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.48
Next Earnings
Feb 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares OutstandingN/A
10 Day Avg. Volume45,360
30 Day Avg. Volume86,479
Standard Deviation0.19
R-Squared0.05
Alpha-0.00328
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)16.38
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bio-Gene Technology Ltd. News
PremiumCompany Announcements
Bio-Gene Technology Strengthens Market Position with Flavocide Progress
PremiumCompany Announcements
Bio-Gene Technology Announces Hybrid AGM for 2024PremiumCompany Announcements
Bio-Gene Unveils Strategy in Investor BriefingPremiumCompany Announcements
Bio-Gene Technology Shares Investor Insights
PremiumCompany Announcements
Bio-Gene’s Breakthrough in Flavocide Production
PremiumCompany Announcements
Bio-Gene Technology Updates Corporate Governance
PremiumCompany Announcements
Bio-Gene Reports Revenue Drop and Lower LossesPremiumCompany Announcements
Bio-Gene and Envu Innovate Against Mosquito ThreatsOptions Prices
Currently, No data available
---
Ownership Overview
7.29%
Insiders
― Other Institutional Investors
92.71% Public Companies and
Individual Investors
BGT FAQ
What was Bio-Gene Technology Ltd.’s price range in the past 12 months?
Bio-Gene Technology Ltd. lowest share price was AU$0.04 and its highest was AU$0.09 in the past 12 months.
What is Bio-Gene Technology Ltd.’s market cap?
Currently, no data Available
When is Bio-Gene Technology Ltd.’s upcoming earnings report date?
Bio-Gene Technology Ltd.’s upcoming earnings report date is Feb 20, 2025 which is in 107 days.
How were Bio-Gene Technology Ltd.’s earnings last quarter?
Currently, no data Available
Is Bio-Gene Technology Ltd. overvalued?
According to Wall Street analysts Bio-Gene Technology Ltd.’s price is currently Overvalued.
Does Bio-Gene Technology Ltd. pay dividends?
Bio-Gene Technology Ltd. does not currently pay dividends.
What is Bio-Gene Technology Ltd.’s EPS estimate?
Bio-Gene Technology Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bio-Gene Technology Ltd. have?
Bio-Gene Technology Ltd. has 201,361,570 shares outstanding.
What happened to Bio-Gene Technology Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bio-Gene Technology Ltd.?
Currently, no hedge funds are holding shares in AU:BGT
---
Bio-Gene Technology Ltd. Stock Smart Score
Company Description
Bio-Gene Technology Ltd.
Bio-Gene Technology Ltd is an Australian biotechnology company engaged in the development and commercialization of insecticide products. It develops a patent protected product platform based on a naturally occurring class of chemicals known as beta-triketones. Its product includes Qcide and Flavocid. Its target applications include agriculture, public health, and consumer and animal health. The firm operates in one business segment namely the conduct of research and development activities in the discovery of novel insecticides.
---
Technical Analysis
Prescient Therapeutics Limited
―
Resonance Health Ltd
―
Sonic Healthcare Limited
―
---